| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |